DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

AcrySof Toric Clinical Results

Information source: Alcon Research
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cataracts; Astigmatism

Intervention: T3 (Device); T4 (Device); T5 (Device)

Phase: Phase 4

Status: Completed

Sponsored by: Alcon Research


This study is an evaluation of visual outcomes of subjects implanted with the AcrySof Toric Intraocular Lenses (IOLs) Models SN60T3, SN60T4, and SN60T5.

Clinical Details

Official title: Clinical Results With the AcrySof Toric Intraocular Lens (IOL)

Study design: Observational Model: Case-Only, Time Perspective: Prospective

Primary outcome: Visual Acuity

Secondary outcome: Postoperative refractive cylinder


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Diagnosed with cataracts; has astigmatism falling in range of AcrySof Toric lens as

assessed by the AcrySof Toric calculator Exclusion Criteria:

- Ocular comorbidities affecting visual outcome data,

- Prior refractive surgery,

- Irregular astigmatism

Locations and Contacts

Alcon Call Center for Trial Locations, Fort Worth, Texas 76134, United States
Additional Information

Starting date: August 2007
Last updated: September 27, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017